The Society of Physician Entrepreneurs and the MBA Collaborative Alumni Angel Group, in conjunction with NIH, cordially invite you to join us for our next meeting:

Summer Healthcare/Life Science Pitch Event

July 24th 2018 5 PM-8 PM

This program will be focused on start-up and emerging biotech, pharmaceutical, Health IT, and healthcare companies. Referrals are coming from NIH officials and consultants as well as SoPE/CAAG members and affiliates.

Call for Start-Ups; Please submit your Executive Summary and non-proprietary Slide deck to This email address is being protected from spambots. You need JavaScript enabled to view it. for consideration to pitch at this upcoming event.

The prospect of Amazon entering the pharma industry with the acquisition of PillPack will be a troubling development for pharma executives around the globe.

The region has only seen one real initial public offering since the beginning of 2017.

Maryland companies raised $247 million in venture capital funding in the second quarter, the sixth consecutive quarter the state has raised at least $100 million.

AstraZeneca’s MedImmune and 4D Molecular Therapeutics forged a collaboration to develop a gene therapy for chronic lung disease.

Want to hear more about cybersecurity and technology in Montgomery County? Check out the personal stories from our most innovative business leaders and entrepreneurs in the fields of IT, BioHealth, life sciences, and more.

The Bill & Melinda Gates Foundation has held a coming-out party for its nonprofit biotech startup. Equipped with plans to build a 120-person team and spend $100 million a year, the Gates Medical Research Institute (MRI) will turn drug industry expertise and processes on intractable diseases that kill millions of people annually in low- and middle-income countries.

Montgomery County companies may soon apply online for the County’s new Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Matching Grant Program. Applications will be accepted beginning at 10 a.m. on Monday, July 16.

Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company focused on infectious disease, today announced it has appointed Mitchel Sayare, Ph.D., as Executive Chairman of the Board, effective immediately. 

Johns Hopkins spinout Clear Guide Medical received a $2 million grant from the National Institutes of Health to apply its imaging tools to pediatrics.

A Baltimore biotechnology company has raised $4 million, to help bring its therapeutic treatment targeting rare genetic diseases closer to market.

Venture funding for Greater Washington companies fell nearly 50 percent in the second quarter from a year ago, but the region's take for the first half of the year remains above last year.

The National Institute of Standards and Technology issued a request for information seeking ideas for improving the public’s return on investment from federally supported R&D. Here’s my submission.

WellDoc®, a leading digital health company, today announces hypertension and weight management solutions integrated within its digital therapeutic app for type 2 diabetes, BlueStar®. Later this year, WellDoc will launch its stand-alone product for individuals living with hypertension (high blood pressure) and stand-alone products are also in development for multiple chronic diseases.

The Washington area is rarely thought of as a hotbed for technology companies. The region’s biggest firms have generally gravitated toward the quiet, stable business of government contracting, while start-ups tend to move elsewhere in search of growth capital.

Teva Pharmaceutical Industries Ltd., the troubled Israeli manufacturer of generic drugs, will be moving its US headquarters from Pennsylvania to New Jersey, lured by 10-year, $40 million tax incentive plan.

Attending the Farm Progress Show at Boone, Iowa, this year? Add the Iowa AgriTech Accelerator to your list of exhibitors to visit.

When Viela Bio spun out of MedImmune in March, it started with six assets — three in clinical trials and three in preclinical development — putting it ahead of most startups and many spin-offs. “Other spin-offs often are developing assets that have been shelved for various reasons or that have been deprioritized,” Bing Yao, Ph.D., CEO, notes. “But for Viela Bio, this is a continuation of the programs, not a handoff.”

TEDCO, Maryland’s economic engine for technology companies, announced its recent investments through the Maryland Innovation Initiative (MII). With the latest round of funding, MII’s funding count for FY18 includes 38 technology assessment grants and seven start-up investments for a total of $5.56 million. True to its technology agnostic funding history, this year the startups ranged from medical devices to aeronautics and the sports industry.

The quest for innovation is a major driving force in pharma. From the discovery of therapeutic biologicals in the 1920s, such as Salvarsan and insulin, to the blockbuster drugs birthed in the 1990s, such as Lipitor and Humira, pharma has always been on a quest for novel, groundbreaking drug development.

Every entrepreneur has a “founder’s story” that serves to build the unique framework for why they are just the right person to solve a specific problem. For Aaron Chang, CEO of Renalert, that story began at Johns Hopkins University in the Masters of Bioengineering Innovation and Design program.

This seed round will send the startup into the next phase of its journey toward clinical trials.

With federal funding, Gemstone Biotherapeutics is eying development of the next generation of its wound-healing technology.

The Federal Hill startup is developing treatments that enable skin regeneration without scars.

WellDoc®, a leading digital health company revolutionizing chronic disease management to help transform lives through the use of its digital therapeutics, today announced results from an innovative economic analysis that demonstrated the potential for significant healthcare cost savings with the use of BlueStar®. BlueStar is powered by WellDoc and is a 510K-cleared digital therapeutic designed to coach adults with type 2 diabetes.

CosmosID a bioinformatics provider and NGS service laboratory announced that the company’s cloud-based bioinformatics platform for microbiome analysis has received the highest score in the strain-level microbial profiling category of the Mosaic Community Challenge and for strain-level microbial identification in the precisionFDA Pathogen Detection Challenge.

gel-e Inc., announces the 510(k) clearance of gel-e FLEX by the U.S. Food and Drug Administration (FDA) for the over-the-counter (OTC) use of its first flowable hemostat.

This new clearance expands the Company's label that now includes the use of gels and bandages in the local management of bleeding, such as lacerations and minor bleeding. These products are specifically designed to create rapid hemostasis through easy-to-use applications for professional healthcare providers, parents, coaches, adult caregivers and even patients themselves. gel-e FLEX also complements the Company's already FDA cleared vascular closure device, Vascular gel-e®, as it can be worn home by patients to manage any residual bleeding from an out-patient diagnostic or interventional procedure, see http://www.gel-e.co/products.html.

Though we’re nowhere near machines taking over, artificial intelligence has a plethora of applications in healthcare. The oncology space is no exception.

The intersection of artificial intelligence and cancer care is up for discussion at the forthcoming MedCity CONVERGE conference in Philadelphia on July 11-12.

Leslie Weber was inducted in June as chair of the board of directors of the Montgomery County Chamber of Commerce. Weber is director of the Johns Hopkins University Montgomery County Campus and director of government and community affairs for Johns Hopkins in Montgomery County. She long has been involved with the Chamber: She has held leadership positions on the board and received the Chairman’s Award in 2016.

The city has begun testing its hypothesis that real estate costs and other hurdles stood in the way of a booming life science sector by supporting three biotech incubators.

Two of the incubators, which offer young companies an affordable workspace, lab equipment and networking opportunities, have started welcoming tenants. But data on the strategy’s success has been sparse.

The Maryland Technology Enterprise Institute (Mtech) at the University of Maryland, College Park seeks an organized, energetic person to assist with operational functions and related activities for the Entrepreneurship and Innovation Program in the Honors College.

This nationally award-winning program helps to develop the entrepreneurial mindsets, skill sets and resources for first and second-year students.

The position-holder would provide coordination and support for

program operations and administration courses and curriculum student activities and engagement marketing and recruiting development and grants

Johns Hopkins University is again the top NIH grant recipient in Greater Baltimore in 2017, with a total grant value of $651.8 million last year.

The university also led all U.S. universities in research and development expenditures for the 38th consecutive year in fiscal year 2016, spending $2.4 billion on various research projects.

Two Rockville employers are among the top workplaces in the region, according to The Washington Post's newest ranking.

There is limited data available on Health Tech investing in general and even less related to early stage investing in the sector. IPHA set out to fill that gap by analyzing quarterly health tech investing data between 2010 through Q1 2018. We track both total investment dollars and deals completed over the period with additional analysis of the five quarters leading up to March 31, 2018. There is an unmistakeable trend reversal that started in Q1 2017 that is significant for both health tech entrepreneurs and investors.

Women and men almost equally shared all positions in the life sciences world, but women are not advancing in their biopharma careers at the same pace as men, according to a recent report by the Massachusetts Biotechnology Council and recruiting firm Liftstream. The wide gender gap higher up, though improved in recent years, persists: Women only hold a quarter of all C-suite level jobs, and less than 15% joined the board of directors.

Lupin has announced that it has partnered with Mylan to commercialize Enbrel (Etanercept) biosimilar. Under the terms of the agreement, Lupin will receive an up-front payment of $15mn and potential commercial milestones together with an equal share in net profits of the product. Mylan will commercialize Lupin's Etanercept biosimilar in Europe, Australia, New Zealand, Latin America, Africa and most markets throughout Asia.